Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Julia Anne Florence has worked on the following 5 EPO patent applications which have been published in the last five years:

EP11755042

DRY POWDER INHALATION DRUG PRODUCTS EXHIBITING MOISTURE CONTROL PROPERTIES AND METHODS OF ADMINISTERING THE SAME

IPC classification:
A61K 9/14, A61K 31/137, A61K 31/58, A61P 11/06
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13803046

COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS

IPC classification:
A61K 9/00, A61K 9/10, A61K 31/4418, A61K 31/58, A61K 47/38
Applicant:
Glaxo Group Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP15172604

DRY POWDER INHALATION DRUG PRODUCTS EXHIBITING MOISTURE CONTROL PROPERTIES AND METHODS OF ADMINISTERING THE SAME

IPC classification:
A61K 9/14, A61K 31/133, A61K 31/137, A61K 31/58, A61P 11/06
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12744272

CATHEPSIN C INHIBITORS

IPC classification:
A01N 43/16, A61K 31/35, C07D 309/14, C07D 405/12
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11755043

DRY POWDER INHALATION DRUG PRODUCTS EXHIBITING MOISTURE CONTROL PROPERTIES AND METHODS OF ADMINISTERING THE SAME

IPC classification:
A61K 9/14, A61K 31/133, A61K 31/137, A61K 31/58, A61P 11/06
Applicant:
GlaxoSmithKline Intellectual Property Limited
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
PATENT GRANTED

Please Sign in to use this feature